Menu

阿那莫林2025年可以在国内买到吗

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Introduction: Anamorelin is a new, oral, selective ghrelin receptor agonist developed and produced by Japan's Ono Pharmaceutical Company. It is mainly used to treat cancer cachexia. This article will explore whether Anamorelin can be purchased in China in 2025, analyze its difficulty in purchasing, and provide precautions for daily use.

Will Anamorelin be available in China in 2025?

It is a drug used to treat cancer cachexia and has been approved for use in some countries. So, will it be available in the country in 2025?

Domestic Approval Progress

Currently, the domestic approval progress of Anamorelin is relatively smooth. According to announcements from relevant departments, the drug has entered the final stage of clinical trials and is expected to complete all approval processes before the end of 2024. Therefore, it is more likely that anamorelin will appear on the domestic market in 2025.

Market Demand

As the incidence of cancer increases, the market demand for anamulin is also increasing. Many domestic hospitals and pharmaceutical companies have expressed strong interest in the drug and are expected to quickly enter the market once approved.

Policy Support

The country’s policy support for innovative drugs continues to increase. Anamorelin, as an innovative drug, is expected to accelerate the launch process under the policy dividend. Therefore, the possibility of purchasing anamulin domestically in 2025 is high.

Anamulin is more likely to be launched in China in 2025, and market demand and policy support will promote its rapid entry into the market.

Is Anamorelin easy to buy?

As a new drug, how easy is it to buy Anamorelin? This is a concern for many patients and families.

Purchase Channels

Once Anamorelin is launched in China, it is expected to be sold through hospital pharmacies and large chain pharmacies. Patients can purchase it at hospital pharmacies with a doctor's prescription or at large chain pharmacies with a prescription.

Price Factor

The price of anamulin may be relatively high, especially in the early stages of its launch. Due to high research and development costs and high market demand, price may become a factor affecting purchase.

The specification of Japan’s Anamorelin is 50mg*100 tablets per box, and the price of a box is about US$465. The price of Laos Lucius’s imitation Anamorelin is about US$413 per box, and the specification of one box is 50mg*100 tablets.

Purchase restrictions

As a prescription drug, Anamorelin requires a doctor’s prescription when purchased. Additionally, purchase quantities may be limited to prevent drug abuse. Therefore, patients need to consult their doctor in advance and prepare relevant procedures when purchasing.

The purchase channels for Anamorelin are relatively clear, but the price and purchase restrictions may have a certain impact on some patients.

Daily Precautions for Anamorelin

As a drug for treating cancer cachexia, what should we pay attention to in daily use of Anamorelin?

Dosage

The dosage of Anamorelin needs to be strictly followed as recommended by your doctor. Overdosing may result in increased side effects, while underdosing may affect efficacy. Therefore, patients should strictly follow the doctor's instructions when taking medication.

Side Effect Management

Anamulin may cause some side effects, such as nausea, vomiting, loss of appetite, etc. Patients should pay close attention to their physical condition during medication and seek medical advice in time if they feel unwell. Doctors may adjust the medication regimen based on the patient's specific condition.

Drug Interactions

Anamulin may interact with other drugs, affecting the efficacy or increasing side effects. Therefore, patients should inform their doctor about other drugs they are taking during medication so that the doctor can make comprehensive assessment and adjustments.

The daily use of Anamorelin requires strict compliance with medical instructions and attention to dosage, side effect management and drug interactions for better medication use.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。